AGOVIRAX may significantly reduce the risk of SARS-CoV-2 infection 20ml

AGOVIRAX may significantly reduce the risk of SARS-CoV-2 infection 20ml

For adjuvant treatment and prevention of viral respiratory infections.
May significantly reduce the risk of SARS-CoV-2 infection and spread of the virus. Suitable for adults and children from 1 year. Can be used by pregnant and breastfeeding women.
AGOVIRAX Nasal Spray is a clear, colorless, viscous solution without odour.
1 ml solution contains 1.2 mg iota-carrageenan (Carragelose®), 0.4 mg kappa-carrageenan, sodium chloride and purified water.
AGOVIRAX use and method of administration
At first signs of a flu-like infection (e.g., throat pain, tingling or runny nose, etc.), one puff should be sprayed at least 3 times daily into each nostril. Treatment should be initiated as early as possible after the onset of the first cold symptoms and continued until the symptoms have subsided. If fever develops or there is no improvement after one week of treatment, a doctor should be consulted.
The AGOVIRAX unique filter system guarantees the sterility of the solution even after repeated use
Due to the advanced technology used in the spray system, such as a metal-free fluid path, a vented preservative-free system, a special filter membrane and tip-seal technology, the product is safeguarded from contamination and remains sterile for 12 months after first use.